ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4(+) T cells by plasmacytoid dendritic cells.

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4(+) T cells by plasmacytoid dendritic cells.
复制标题

DOI:
10.4161/onci.23185
复制
发表时间:
2013-03-01
期刊:
影响因子:
7.2
通讯作者:
Ménétrier-Caux C
Ménétrier-Caux C
中科院分区:
医学2区
文献类型:
--
作者:
Faget J;Sisirak V;Blay JY;Caux C;Bendriss-Vermare N;Ménétrier-Caux C

文献摘要

参考文献

被引文献

相似文献

浸润原发性乳腺肿瘤的调节性T细胞(TCFs)和浆细胞样树突状细胞(pDC)损害患者的生存率。肿瘤浸润性CD 4 + T细胞和pDC之间的ICOS介导的相互作用导致T细胞增殖和白细胞介素-10分泌。重要的是,ICOS+细胞浸润与不良患者预后相关,将ICOS确定为癌症免疫治疗的新靶点。
Regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) that infiltrate primary breast tumors impair patient survival. The ICOS-mediated interaction between tumor-infiltrating CD4+ T cells and pDCs leads to the amplification of Tregs and interleukin-10 secretion. Importantly, ICOS+ cell infiltration correlates with adverse patient prognosis, identifying ICOS as a new target for cancer immunotherapy.
DOI: 10.1158/0008-5472.can-08-2360
发表时间: 2009-03-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Gobert, Michael;Treilleux, Isabelle;Menetrier-Caux, Christine
通讯作者: Menetrier-Caux, Christine
鼠调节T细胞含有具有差异ICOS表达的高增殖性和易死的子集。
DOI: 10.4049/jimmunol.1102448
发表时间: 2012-02-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Chen Y;Shen S;Gorentla BK;Gao J;Zhong XP
通讯作者: Zhong XP
DOI: 10.1158/0008-5472.can-12-2409
发表时间: 2012-12-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Faget, Julien;Bendriss-Vermare, Nathalie;Menetrier-Caux, Christine
通讯作者: Menetrier-Caux, Christine
DOI: 10.1158/0008-5472.can-11-1138
发表时间: 2011-08-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Fu, Tihui;He, Qiuming;Sharma, Padmanee
通讯作者: Sharma, Padmanee
DOI: 10.1073/pnas.0712237105
发表时间: 2008-02-26
影响因子: 11.1
作者:
Hodi, F. Stephen;Butler, Marcus;Dranoff, Glenn
通讯作者: Dranoff, Glenn